Why Arcus Biosciences Stock Is Skyrocketing Today
Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage oncology company, is up big this morning. Specifically, the drugmaker's shares are up by an astounding 84% as of 10:16 a.m. EDT Thursday morning.
What's sparking this monstrous move higher? In pre-market action, a rumor surfaced that Gilead Sciences (NASDAQ: GILD) was considering an equity stake in Arcus. This move, if it does indeed come to fruition, would give the biotech heavyweight access to the company's robust, yet fairly early-stage pipeline of unique immuno-oncology assets, such as the anti-TIGIT monoclonal antibody AB154.
Image Source: Getty Images.
Source Fool.com
